Pharma Goes Direct: Redefining the Patient Relationship

Pharma’s commercial model is evolving fast as direct-to-consumer engagement moves from marketing experiment to strategic channel. Companies are building end-to-end ecosystems for prescribing, fulfillment, adherence, and support—combining clinical credibility with consumer-grade experience. This shift raises critical questions about how to earn patient trust, manage data responsibly, and deliver measurable outcomes while maintaining regulatory integrity.

Join us to discuss:

• How are pharma companies balancing compliance and innovation as they build D2C channels that extend beyond awareness to care delivery?

• What partnership, platform, and data strategies enable trusted, seamless patient journeys across digital and in-person touchpoints?

• Which D2C models are demonstrating sustained clinical and commercial value—and what lessons can be applied across therapeutic areas?